De novo Diagnosis of Fabry Disease among Italian Adults with Acute Ischemic Stroke or Transient Ischemic Attack

Ilaria Romani, Walter Borsini, Patrizia Nencini, Amelia Morrone, Lorenzo Ferri, Sabrina Frusconi, Vincenzo Angelo Donadio, Rocco Liguori, Maria Alice Donati, Serena Falconi, Giovanni Pracucci, Domenico Inzitari

Research output: Contribution to journalArticle

Abstract

Background and purpose: Cerebrovascular complications are often the first cause of hospitalization in patients with Fabry disease (FD). Screenings for FD among stroke patients have yielded discrepant results, likely as a result of heterogeneous or incomplete assessment. We designed a study to identify FD among adults 60 years of age or younger who were consecutively admitted for acute ischemic stroke or transient ischemic attack (TIA) to a stroke neurology service in Italy. Methods: Patients with first-ever or recurrent events were included, irrespective of gender, risk factors, or stroke type. We screened male patients using α-galactosidase A enzyme assay, and female patients using DNA sequencing. FD was eventually established after a broad multidisciplinary discussion. Results: We screened 108 patients (61% males, median age: 48 years); 84% of these patients had stroke. De novo FD diagnosis was established in 3 patients (2.8%; 95% confidence interval,.57-8.18): a 59-year-old man with recurrent lacunar-like strokes and multiple risk factors; a 42-year-old woman with recurrent cryptogenic minor strokes; and a 32-year-old woman with recurrent strokes previously attributed to Behçet's disease. Screened patients were systematically asked for typical FD symptoms; each of the de novo patients reported one or more of the following: episodes of hand/foot pain during fever, angiokeratoma, and family history of heart disease. In all of the patients events were recurrent, and lacunar-like infarcts characterized their brain imaging. Conclusions: Prevalence of FD among nonselected adults 60 years of age or younger with acute ischemic stroke or TIA is not negligible. A systematic search for FD in a stroke setting, using a comprehensive clinical, biochemical, and genetic screening protocol, may be worthwhile.

Original languageEnglish
Pages (from-to)2588-2595
Number of pages8
JournalJournal of Stroke and Cerebrovascular Diseases
Volume24
Issue number11
DOIs
Publication statusPublished - Nov 1 2015

Fingerprint

Fabry Disease
Transient Ischemic Attack
Stroke
Lacunar Stroke
Angiokeratoma
Galactosidases
Enzyme Assays
Genetic Testing
Neurology
DNA Sequence Analysis
Neuroimaging
Italy
Foot
Molecular Biology
Heart Diseases
Hospitalization
Fever
Hand

Keywords

  • Acute ischemic stroke
  • Fabry disease
  • GLA gene variants
  • Screening in epidemiology

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery
  • Rehabilitation
  • Cardiology and Cardiovascular Medicine

Cite this

De novo Diagnosis of Fabry Disease among Italian Adults with Acute Ischemic Stroke or Transient Ischemic Attack. / Romani, Ilaria; Borsini, Walter; Nencini, Patrizia; Morrone, Amelia; Ferri, Lorenzo; Frusconi, Sabrina; Donadio, Vincenzo Angelo; Liguori, Rocco; Donati, Maria Alice; Falconi, Serena; Pracucci, Giovanni; Inzitari, Domenico.

In: Journal of Stroke and Cerebrovascular Diseases, Vol. 24, No. 11, 01.11.2015, p. 2588-2595.

Research output: Contribution to journalArticle

Romani, I, Borsini, W, Nencini, P, Morrone, A, Ferri, L, Frusconi, S, Donadio, VA, Liguori, R, Donati, MA, Falconi, S, Pracucci, G & Inzitari, D 2015, 'De novo Diagnosis of Fabry Disease among Italian Adults with Acute Ischemic Stroke or Transient Ischemic Attack', Journal of Stroke and Cerebrovascular Diseases, vol. 24, no. 11, pp. 2588-2595. https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.07.012
Romani, Ilaria ; Borsini, Walter ; Nencini, Patrizia ; Morrone, Amelia ; Ferri, Lorenzo ; Frusconi, Sabrina ; Donadio, Vincenzo Angelo ; Liguori, Rocco ; Donati, Maria Alice ; Falconi, Serena ; Pracucci, Giovanni ; Inzitari, Domenico. / De novo Diagnosis of Fabry Disease among Italian Adults with Acute Ischemic Stroke or Transient Ischemic Attack. In: Journal of Stroke and Cerebrovascular Diseases. 2015 ; Vol. 24, No. 11. pp. 2588-2595.
@article{dfd0e4e04ade4dd5a0d262bdaf127b68,
title = "De novo Diagnosis of Fabry Disease among Italian Adults with Acute Ischemic Stroke or Transient Ischemic Attack",
abstract = "Background and purpose: Cerebrovascular complications are often the first cause of hospitalization in patients with Fabry disease (FD). Screenings for FD among stroke patients have yielded discrepant results, likely as a result of heterogeneous or incomplete assessment. We designed a study to identify FD among adults 60 years of age or younger who were consecutively admitted for acute ischemic stroke or transient ischemic attack (TIA) to a stroke neurology service in Italy. Methods: Patients with first-ever or recurrent events were included, irrespective of gender, risk factors, or stroke type. We screened male patients using α-galactosidase A enzyme assay, and female patients using DNA sequencing. FD was eventually established after a broad multidisciplinary discussion. Results: We screened 108 patients (61{\%} males, median age: 48 years); 84{\%} of these patients had stroke. De novo FD diagnosis was established in 3 patients (2.8{\%}; 95{\%} confidence interval,.57-8.18): a 59-year-old man with recurrent lacunar-like strokes and multiple risk factors; a 42-year-old woman with recurrent cryptogenic minor strokes; and a 32-year-old woman with recurrent strokes previously attributed to Beh{\cc}et's disease. Screened patients were systematically asked for typical FD symptoms; each of the de novo patients reported one or more of the following: episodes of hand/foot pain during fever, angiokeratoma, and family history of heart disease. In all of the patients events were recurrent, and lacunar-like infarcts characterized their brain imaging. Conclusions: Prevalence of FD among nonselected adults 60 years of age or younger with acute ischemic stroke or TIA is not negligible. A systematic search for FD in a stroke setting, using a comprehensive clinical, biochemical, and genetic screening protocol, may be worthwhile.",
keywords = "Acute ischemic stroke, Fabry disease, GLA gene variants, Screening in epidemiology",
author = "Ilaria Romani and Walter Borsini and Patrizia Nencini and Amelia Morrone and Lorenzo Ferri and Sabrina Frusconi and Donadio, {Vincenzo Angelo} and Rocco Liguori and Donati, {Maria Alice} and Serena Falconi and Giovanni Pracucci and Domenico Inzitari",
year = "2015",
month = "11",
day = "1",
doi = "10.1016/j.jstrokecerebrovasdis.2015.07.012",
language = "English",
volume = "24",
pages = "2588--2595",
journal = "Journal of Stroke and Cerebrovascular Diseases",
issn = "1052-3057",
publisher = "W.B. Saunders Ltd",
number = "11",

}

TY - JOUR

T1 - De novo Diagnosis of Fabry Disease among Italian Adults with Acute Ischemic Stroke or Transient Ischemic Attack

AU - Romani, Ilaria

AU - Borsini, Walter

AU - Nencini, Patrizia

AU - Morrone, Amelia

AU - Ferri, Lorenzo

AU - Frusconi, Sabrina

AU - Donadio, Vincenzo Angelo

AU - Liguori, Rocco

AU - Donati, Maria Alice

AU - Falconi, Serena

AU - Pracucci, Giovanni

AU - Inzitari, Domenico

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Background and purpose: Cerebrovascular complications are often the first cause of hospitalization in patients with Fabry disease (FD). Screenings for FD among stroke patients have yielded discrepant results, likely as a result of heterogeneous or incomplete assessment. We designed a study to identify FD among adults 60 years of age or younger who were consecutively admitted for acute ischemic stroke or transient ischemic attack (TIA) to a stroke neurology service in Italy. Methods: Patients with first-ever or recurrent events were included, irrespective of gender, risk factors, or stroke type. We screened male patients using α-galactosidase A enzyme assay, and female patients using DNA sequencing. FD was eventually established after a broad multidisciplinary discussion. Results: We screened 108 patients (61% males, median age: 48 years); 84% of these patients had stroke. De novo FD diagnosis was established in 3 patients (2.8%; 95% confidence interval,.57-8.18): a 59-year-old man with recurrent lacunar-like strokes and multiple risk factors; a 42-year-old woman with recurrent cryptogenic minor strokes; and a 32-year-old woman with recurrent strokes previously attributed to Behçet's disease. Screened patients were systematically asked for typical FD symptoms; each of the de novo patients reported one or more of the following: episodes of hand/foot pain during fever, angiokeratoma, and family history of heart disease. In all of the patients events were recurrent, and lacunar-like infarcts characterized their brain imaging. Conclusions: Prevalence of FD among nonselected adults 60 years of age or younger with acute ischemic stroke or TIA is not negligible. A systematic search for FD in a stroke setting, using a comprehensive clinical, biochemical, and genetic screening protocol, may be worthwhile.

AB - Background and purpose: Cerebrovascular complications are often the first cause of hospitalization in patients with Fabry disease (FD). Screenings for FD among stroke patients have yielded discrepant results, likely as a result of heterogeneous or incomplete assessment. We designed a study to identify FD among adults 60 years of age or younger who were consecutively admitted for acute ischemic stroke or transient ischemic attack (TIA) to a stroke neurology service in Italy. Methods: Patients with first-ever or recurrent events were included, irrespective of gender, risk factors, or stroke type. We screened male patients using α-galactosidase A enzyme assay, and female patients using DNA sequencing. FD was eventually established after a broad multidisciplinary discussion. Results: We screened 108 patients (61% males, median age: 48 years); 84% of these patients had stroke. De novo FD diagnosis was established in 3 patients (2.8%; 95% confidence interval,.57-8.18): a 59-year-old man with recurrent lacunar-like strokes and multiple risk factors; a 42-year-old woman with recurrent cryptogenic minor strokes; and a 32-year-old woman with recurrent strokes previously attributed to Behçet's disease. Screened patients were systematically asked for typical FD symptoms; each of the de novo patients reported one or more of the following: episodes of hand/foot pain during fever, angiokeratoma, and family history of heart disease. In all of the patients events were recurrent, and lacunar-like infarcts characterized their brain imaging. Conclusions: Prevalence of FD among nonselected adults 60 years of age or younger with acute ischemic stroke or TIA is not negligible. A systematic search for FD in a stroke setting, using a comprehensive clinical, biochemical, and genetic screening protocol, may be worthwhile.

KW - Acute ischemic stroke

KW - Fabry disease

KW - GLA gene variants

KW - Screening in epidemiology

UR - http://www.scopus.com/inward/record.url?scp=84946486000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946486000&partnerID=8YFLogxK

U2 - 10.1016/j.jstrokecerebrovasdis.2015.07.012

DO - 10.1016/j.jstrokecerebrovasdis.2015.07.012

M3 - Article

C2 - 26298600

AN - SCOPUS:84946486000

VL - 24

SP - 2588

EP - 2595

JO - Journal of Stroke and Cerebrovascular Diseases

JF - Journal of Stroke and Cerebrovascular Diseases

SN - 1052-3057

IS - 11

ER -